Literature DB >> 29251374

Synthesis and elastase inhibition activities of novel aryl, substituted aryl, and heteroaryl oxime ester derivatives.

Belma Hasdemir1, Ozlem Sacan2, Hasniye Yasa1, Hatice B Kucuk1, Ayse S Yusufoglu1, Refiye Yanardag2.   

Abstract

Fifteen novel aryl, substituted aryl and heteroaryl γ-hydroxy- (2a-e), γ-methoxyimino- (3a-e), and γ-benzyloxyimino- (4a-e) butyric acid methyl esters were investigated for their enzyme inhibition, and the synthesis of 10 compounds (3a-e, 4a-e) is given in this study. The other five compounds (2a-e) were synthesized before in another study. Compounds 3a-e and 4a-e were synthesized in this work as original compounds and characterized by 1 H and 13 C NMR, IR, mass, and elemental analyses. Their (E/Z)-isomerisation ratios were analyzed by 1 H and 13 C NMR. All of them are of pure (E)-configuration. Due to the literature survey, the elastase inhibition activity was not studied for these compounds. Elastase inhibition ability was investigated in this work for five γ-hydroxy- (2a-e), five γ-methoxy- (3a-e), and five γ-benzyloxyimino- (4a-e) butyric acid methyl esters. All these 15 compounds showed elastase inhibition activity. Compound 2b was the best one and exhibited a better activity than the standard ursolic acid whereas compound 2a worked like the standard. All these compounds can be novel elastase inhibitor agents in the pharmaceutical and cosmetic industries.
© 2017 Deutsche Pharmazeutische Gesellschaft.

Entities:  

Keywords:  elastase inhibition; oxime ester derivatives; ursolic acid

Mesh:

Substances:

Year:  2017        PMID: 29251374     DOI: 10.1002/ardp.201700269

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  1 in total

1.  Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity.

Authors:  Beata Donarska; Marta Świtalska; Joanna Wietrzyk; Wojciech Płaziński; Magdalena Mizerska-Kowalska; Barbara Zdzisińska; Krzysztof Z Łączkowski
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.